
Sign up to save your podcasts
Or


So why does myeloma come back, why is there no cure? Why do some people with myeloma respond to certain treatments and others do not? In this episode Professor Andrew Spencer walks us through the new Myeloma Australia resource about relapsed and refractory myeloma. He answers some of these complex questions in a systematic and easy to understand way. Firstly, Professor Andrew Spencer will give us a refresh on myeloma and then go into more detail about relapsed and refractory myeloma, the criteria the PBS set for commencing new treatment, considerations haematologist's take into account when a patient relapses or becomes refractory to treatment, understanding why myeloma comes back, how myeloma behaves over time, new symptoms to report to the haematologist, clinical trials and logistical mechanisms to support regional/rural patients on a clinical trial.
www.myeloma.org.au/relapse and refractory myeloma book
www.clinicaltrials.org
By Myeloma AustraliaSo why does myeloma come back, why is there no cure? Why do some people with myeloma respond to certain treatments and others do not? In this episode Professor Andrew Spencer walks us through the new Myeloma Australia resource about relapsed and refractory myeloma. He answers some of these complex questions in a systematic and easy to understand way. Firstly, Professor Andrew Spencer will give us a refresh on myeloma and then go into more detail about relapsed and refractory myeloma, the criteria the PBS set for commencing new treatment, considerations haematologist's take into account when a patient relapses or becomes refractory to treatment, understanding why myeloma comes back, how myeloma behaves over time, new symptoms to report to the haematologist, clinical trials and logistical mechanisms to support regional/rural patients on a clinical trial.
www.myeloma.org.au/relapse and refractory myeloma book
www.clinicaltrials.org

11 Listeners